|
Stockholders' Equity (Narrative) (Details) (USD $)
|
12 Months Ended | 1 Months Ended | 12 Months Ended | 1 Months Ended | 12 Months Ended | 1 Months Ended | 12 Months Ended | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Dec. 31, 2011
years
|
Dec. 31, 2010
|
Dec. 31, 2009
|
Jan. 31, 2010
January 2010 Stock Repurchase Program; $1B [Member]
|
Oct. 31, 2007
October 2007 Stock Repurchase Program; $3B [Member]
|
Jan. 31, 2011
January 2011 Stock Repurchase Program; $5B, 3-Year [Member]
|
Dec. 31, 2011
January 2011 Stock Repurchase Program; $5B, 3-Year [Member]
|
May 31, 2010
May 2010 Stock Repurchase Program; $5B, 3-Year [Member]
|
Dec. 31, 2010
May 2010 Stock Repurchase Program; $5B, 3-Year [Member]
|
Dec. 31, 2011
Series A Junior Participating Preferred Stock [Member]
|
Apr. 30, 2009
CV Therapeutics Plans [Member]
|
Dec. 31, 2011
General Rights Plan [Member]
|
Dec. 31, 2011
Stock Option Plans [Member]
years
|
Dec. 31, 2011
Two Thousand Four Plan [Member]
|
Dec. 31, 2011
Performance Based Share Awards [Member]
years
|
Dec. 31, 2010
Performance Based Share Awards [Member]
|
Dec. 31, 2009
Performance Based Share Awards [Member]
|
Dec. 31, 2011
Employee Stock Purchase Plan [Member]
years
|
Dec. 31, 2011
Restricted Stock Units (RSUs) [Member]
years
|
Dec. 31, 2010
Restricted Stock Units (RSUs) [Member]
|
Dec. 31, 2009
Restricted Stock Units (RSUs) [Member]
|
Oct. 31, 1999
Maximum [Member]
First Amendment of Rights Plan [Member]
|
Oct. 31, 2003
Maximum [Member]
Second Amendment of Rights Plan [Member]
|
Oct. 31, 1999
Minimum [Member]
First Amendment of Rights Plan [Member]
|
Oct. 31, 2003
Minimum [Member]
Second Amendment of Rights Plan [Member]
|
|
| Equity Issuance Since Inception [Line Items] | |||||||||||||||||||||||||
| Authorized common stock repurchase program | $ 1,000,000,000 | $ 3,000,000,000 | $ 5,000,000,000 | $ 5,000,000,000 | |||||||||||||||||||||
| Aggregate purchase price of the stock repurchased and retired under the stock repurchase programs | 2,380,000,000 | 4,020,000,000 | 998,100,000 | 403,100,000 | 3,020,000,000 | ||||||||||||||||||||
| Number of shares retired under the stock repurchase programs | 59,900,000 | 109,900,000 | 21,800,000 | ||||||||||||||||||||||
| Incremental common shares attributable to accelerated share repurchase agreements | 1,400,000 | ||||||||||||||||||||||||
| Average purchase price per share of the stock repurchased and retired under the stock repurchase programs | $ 45.69 | $ 39.80 | $ 36.57 | ||||||||||||||||||||||
| Remaining authorized amount of stock repurchases | 4,600,000,000 | 1,980,000,000 | |||||||||||||||||||||||
| Decrease in common stock and APIC | 186,200,000 | 319,800,000 | 61,700,000 | ||||||||||||||||||||||
| Excess of purchase price over par value charged against retained earnings | 2,210,000,000 | 3,710,000,000 | 940,800,000 | ||||||||||||||||||||||
| Preferred stock, shares authorized | 5,000,000 | 5,000,000 | 800,000 | ||||||||||||||||||||||
| Preferred stock, shares outstanding | 0 | 0 | |||||||||||||||||||||||
| Preferred Stock, Participation Rights | The Rights Plan provides for the distribution of a preferred stock purchase right as a dividend for each share of our common stock. The purchase rights are not currently exercisable. Under certain conditions involving an acquisition or proposed acquisition by any person or group of 15% or more of our common stock, the purchase rights permit the holders (other than the 15% holder) to purchase our common stock at a 50% discount from the market price at that time, upon payment of a specified exercise price per purchase right. In addition, in the event of certain business combinations, the purchase rights permit the purchase of the common stock of an acquirer at a 50% discount from the market price at that time. Under certain conditions, the purchase rights may be redeemed by our Board in whole, but not in part, at a price of $0.0025 per purchase right. The purchase rights have no voting privileges and are attached to and automatically trade with our common stock. |
||||||||||||||||||||||||
| Number of shares authorized for future issuance | 47,406,212 | ||||||||||||||||||||||||
| Options assumed from acquisition and converted into options to purchase common stock | 1,800,000 | ||||||||||||||||||||||||
| Number of shares authorized for grant | 121,594,183 | ||||||||||||||||||||||||
| Total intrinsic value of options exercised | 194,500,000 | 262,300,000 | 379,800,000 | ||||||||||||||||||||||
| Total fair value of stock options vested | 96,400,000 | 124,600,000 | 162,900,000 | ||||||||||||||||||||||
| Number of options outstanding that are expected to vest | 8,734,108 | ||||||||||||||||||||||||
| Weighted average exercise price of options outstanding that are expected to vest | $ 43.79 | ||||||||||||||||||||||||
| Intrinsic Value of options outstanding that are expected to vest | 10,300,000 | ||||||||||||||||||||||||
| Weighted average remaining contractual life of options outstanding that are expected to vest, years | 7.6 | ||||||||||||||||||||||||
| Aggregate intrinsic value of stock options outstanding | 557,200,000 | ||||||||||||||||||||||||
| Aggregate intrinsic value of stock options exercisable | 545,800,000 | ||||||||||||||||||||||||
| Weighted-average remaining contractual life for options outstanding, years | 4.8 | ||||||||||||||||||||||||
| Weighted-average remaining contractual life for options exercisable, years | 4.1 | ||||||||||||||||||||||||
| Unrecognized compensation cost related to equity awards | 163,000,000 | 26,900,000 | 7,300,000 | 218,900,000 | |||||||||||||||||||||
| Unrecognized compensation costs, weighted-average period of recognition, years | 2.4 | 1.3 | 1.4 | 3.3 | |||||||||||||||||||||
| Share based awards granted | 603,400 | 412,505 | 426,305 | 4,215,000 | 1,974,000 | 1,368,000 | |||||||||||||||||||
| Payout percentage, minimum | 0.00% | ||||||||||||||||||||||||
| Payout percentage, maximum | 200.00% | ||||||||||||||||||||||||
| Share based awards weighted-average grant date fair values | $ 38.44 | $ 54.25 | $ 61.89 | $ 38.79 | $ 40.90 | $ 48.24 | |||||||||||||||||||
| Stock-based compensation expense | 192,378,000 | 200,041,000 | 185,758,000 | 24,600,000 | 21,300,000 | 14,900,000 | |||||||||||||||||||
| Awards vesting period | three | ||||||||||||||||||||||||
| Percentage of purchase price lower than fair market value of common stock | 85.00% | ||||||||||||||||||||||||
| Shares issued under Employee Stock Purchase Plan | 1,199,739 | ||||||||||||||||||||||||
| Value of shares issued under Employee Stock Purchase Plan | 35,013,000 | 32,307,000 | 34,873,000 | 35,000,000 | |||||||||||||||||||||
| Shares reserved for issuance | 33,280,000 | ||||||||||||||||||||||||
| Shares available for issuance | 5,367,672 | ||||||||||||||||||||||||
| Percentage proposed acquisition by group | 15.00% | ||||||||||||||||||||||||
| Discount from the market price | 50.00% | ||||||||||||||||||||||||
| Price per purchase right that may be redeemed by our board in whole | $ 0.0025 | ||||||||||||||||||||||||
| The exercise price of each class of warrants or rights outstanding | 100 | 400 | 15 | 100 | |||||||||||||||||||||
| Maximum shares of full value awards | 25,000,000 | ||||||||||||||||||||||||
| Total fair value of RSUs that vested | $ 25,400,000 | $ 13,100,000 | $ 1,700,000 | ||||||||||||||||||||||